| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1996;27:804-810.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.
Correspondence to Sandra L. Pfister, PhD, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226.
| Abstract |
|---|
|
|
|---|
Key Words: endothelium cholesterol nitric oxide prostaglandins vasoconstriction
| Introduction |
|---|
|
|
|---|
Contracting factors are also produced by the vascular endothelium.4 Yanagisawa and Masaki17 identified the potent peptide vasoconstrictor endothelin. We and others have identified the arachidonic acid metabolite TXA2 as the endothelium-dependent contracting factor in rabbit pulmonary vessels.18 19 Many studies have reported augmented contractions to serotonin and depressed contractions to norepinephrine in coronary arteries and aortas obtained from atherosclerotic compared with normal animals.20 21 22 However, less is understood about the role of endothelium-dependent contracting factor or endothelin in atherosclerosis. It is accepted that the platelet production of TXA2 is enhanced in atherosclerosis.11 In addition, very little is known about the regulation of vascular tone in the pulmonary vasculature of cholesterol-fed animals. The reason for the lack of studies is unclear because it is known that human pulmonary hypertension is often associated with pulmonary artery atherosclerotic lesions.23 24 25
An important point to be emphasized about the abovementioned studies relates to the period of cholesterol feeding. In most cases, animals were fed the diet for a period long enough to produce atherosclerotic lesions, at which point vascular changes were assessed. Because cholesterol is believed to be a major risk factor in cardiovascular disease, we are interested in investigating the early changes that occur in blood vessels before the development of the atherosclerotic lesion. In the present study, we characterized the role of endothelium-derived factors in the responses to methacholine in pulmonary arteries from cholesterol-fed rabbits.
| Methods |
|---|
|
|
|---|
Vascular Reactivity
Pulmonary artery tissue was isolated as
previously
described.19 Briefly, normal and
cholesterol-fed rabbits were killed (sodium
pentobarbital, 120 mg/kg IV) and the heart and lungs were removed as a
unit and placed immediately in a Krebs' bicarbonate buffer of the
following composition (mmol/L): NaCl 118, KCl 4, CaCl2 3.3,
NaHCO3 24, KH2PO4 1.4,
MgSO4 1.2, and glucose 11, pH 7.4. The main
pulmonary artery was identified at its origin from the right
ventricle, and both left and right pulmonary arteries were
dissected to their most distal end. The pulmonary artery distal
to the first branching of the left or right pulmonary artery
was used and is referred to as the intrapulmonary artery.
After dissection, the tissue was cleaned of adherent lung parenchyma
and connective tissue, with care taken to not disturb the
endothelial layer. Rings of intrapulmonary
artery were obtained (2 to 3 mm) and suspended in 15-mL organ baths
containing Krebs' bicarbonate buffer that was warmed to 37°C and
continuously aerated with 95% O2/5%
CO2. Isometric tension was measured with
force-displacement transducers (Grass Instrument Co) and
recorded with a polygraph (Grass model 7D). Resting tension was
adjusted to 1 g, the length-tension maxima, and the vessels were
allowed to equilibrate for 1 hour. Contractions were produced by
raising the KCl concentration of the baths to 40 mmol/L. After the
vessels had reproducible, stable contractions to KCl, cumulative
concentration-response curves to methacholine
(10-8 to
10-4 mol/L),
arachidonic acid (10-8
to 10-5 mol/L), the TXA2
mimetic U46619 (10-11 to
10-7 mol/L), or
norepinephrine (10-8 to
10-5 mol/L) were determined. In some
experiments, the vessels were pretreated with the NO synthase
inhibitor LNA (3x10-5
mol/L) for 10 minutes before methacholine administration. These
experiments were repeated in the presence of L-arginine
(10-4 mol/L). A separate experiment
examined the effect of pretreatment with the calcium-dependent
potassium channel blocker charybdotoxin
(5x10-9 mol/L) for 45 minutes before
methacholine administration. To standardize for any minor differences
in the size of the tissue, we expressed contractile responses as a
percentage of the maximal response to 40 mmol/L KCl. In some
experiments, the vascular responses were investigated in precontracted
vessels. Isolated rings of pulmonary arteries from normal and
cholesterol-fed rabbits were suspended in organ baths
as described above. Norepinephrine
(10-7 mol/L) was added to precontract
the vessels. Once a stable response was obtained, cumulative
concentration-response curves to methacholine were measured.
Results are expressed as the percent relaxation of the
norepinephrine contraction.
Radioimmunoassay
Synthesis of TXA2 and
PGI2 was compared
in cholesterol-fed and normal rabbit pulmonary
arteries. Segments of intrapulmonary arteries were obtained
from both normal and cholesterol-fed rabbits and
incubated for 30 minutes at 37°C in HEPES buffer containing
methacholine (10-5 mol/L). Synthesis of
TXB2, the stable metabolite of
TXA2, and
6-keto-PGF1
, the stable metabolite of
PGI2, was measured in the buffer by specific
radioimmunoassays with the method of Campbell and Ojeda.26
The antibody for TXB2 and
6-keto-PGF1
was produced in rabbits. The
sensitivity of the assay is 1 pg/0.3 mL for TXB2 and 5
pg/0.3 mL for 6-keto-PGF1
. The
cross-reactivity of the antisera with known
arachidonic acid metabolites is less than 0.1%.
NO Synthase Activity
Pulmonary arteries were obtained from
cholesterol-fed rabbits and rabbits fed a standard
rabbit chow as described above. The vessels were minced with a razor
blade and washed with HEPES buffer. Vessels were lysed with a buffer
(pH 7.4) of the following composition: 11 mmol/L HEPES, 350 mmol/L
sucrose, 0.1 mmol/L EDTA, 1 mmol/L dithiothreitol, 10 µg/mL
leupeptin, 2 µg/mL aprotinin, 10 µg/mL soybean trypsin
inhibitor, 10 µg/mL phenylmethylsulfonyl
fluoride, 1% NP-40, and 10% glycerol. Total protein content
was determined in the extracts by the Bradford technique (Bio-Rad) with
albumin as a standard. NO synthase activity in the
pulmonary artery lysates was determined by monitoring the
conversion of [3H]arginine to
[3H]citrulline according to the method of Hevel and
Marletta.27 For the NO synthase assay, samples were
incubated in a 100-µL reaction volume of buffer containing 50 mmol/L
Tris-HCl, 0.1 mmol/L EDTA, 0.1% mercaptoethanol, 100 µmol/L
leupeptin, 1 mmol/L phenylmethylsulfonyl fluoride, 10 µg/mL
soybean trypsin inhibitor, 2 µg/mL aprotinin, 10 nmol/L
calmodulin, 1 mmol/L NADPH, 3 µmol/L tetrahydrobiopterin,
10 µmol/L L-arginine, 0.2 µCi
[3H]L-arginine (66 Ci/mmol), 2.5 mmol/L
calcium chloride, and 100 µg protein. Samples were incubated for 15
minutes at 37°C, and the reaction was stopped by addition of 1 mL
stop buffer (20 mmol/L HEPES and 2 mmol/L EGTA at pH 5.5). In some
samples, LNA (3x10-5 mol/L) was
included. [3H]Citrulline was separated from
[3H]arginine by applying the entire sample over a Dowex
cation-exchange column (Na+ form) that had been
preequilibrated with the stop buffer. [3H]Citrulline was
eluted with distilled water and radioactivity determined with a liquid
scintillation counter. NO synthase activity is expressed as femtomoles
of [3H]citrulline produced per milligram protein per
minute.
Nitrite/Nitrate Determination
For these experiments, isolated
rings of pulmonary
arteries from normal and cholesterol-fed rabbits were
incubated with methacholine (10-5
mol/L) in HEPES buffer at 37°C for 60 minutes. Incubation buffer was
saved and stored at -20°C until assayed. The production of
nitrate (NO3-) and nitrite
(NO2-) in the incubation buffer was
determined by a QuickChem AE Automated Ion Analyzer (Lachat
Instruments) with the method of Pratt et al.28 The samples
were automatically injected into this two-channel detector; one
channel is for NO2- and the other for
NO3-. The
NO3- channel has a cadmium column that
reduces the NO3- to
NO2-. The
NO2- species is reacted with Greiss
reagent to form an azo compound.29 The absorption of both
channels is detected with a 520-nm filter. The minimal detectable
concentration is 25 nmol/L. Standard curves are constructed from serial
dilutions of sodium nitrate in HEPES buffer.
Statistical Analysis
Data are expressed as mean±SE.
Statistical analysis of
the data was performed with ANOVA to determine differences within
groups and Student's t test to determine differences
between groups.
Materials
Norepinephrine, arachidonic acid,
LNA, and methacholine were from Sigma Chemical Co. U46619 was obtained
from Caymen Chemical. Charybdotoxin was from Research Biochemicals
International. Unless otherwise specified, drugs were dissolved in
distilled water such that volumes of 0.05 mL were added to the tissue
baths. Charybdotoxin and LNA were dissolved in Krebs' bicarbonate
buffer. Arachidonic acid and U46619 were prepared in
ethanol previously sparged with nitrogen. The stock solution and
dilutions were made fresh for each experiment and were kept on ice
under a nitrogen atmosphere. The final ethanol concentration of the
bath was less than 0.07%. Control experiments indicated that ethanol
vehicle had no effect on basal tone or on the response of the
vasoactive compounds. Cholesterol was obtained from ICN
Biomedicals.
| Results |
|---|
|
|
|---|
|
We measured the effect of arachidonic acid on vascular
responses in the two groups and found that contractions to
arachidonic acid were not different in
cholesterol-fed and normal rabbits (Fig 2A
).
The TXA2 mimetic U46619 also produced contractions in
cholesterol-fed rabbit pulmonary arteries that
were similar to those in normal rabbits (Fig 2B
). Vessels from
normal
and cholesterol-fed rabbits were incubated with
methacholine, and the release of TXB2 and
6-keto-PGF1
was measured. Results are shown
in Table 1
and indicated that under both basal and
stimulated conditions, production of TXB2 and
6-keto-PGF1
was similar in both groups.
|
|
The next experiments investigated relaxation responses in
pulmonary arteries from cholesterol-fed and
normal rabbits. In norepinephrine-precontracted
vessels, methacholine caused only a small dilation response in normal
NZW rabbits (Fig 3
; maximal relaxation, 27±5%). In
contrast, in pulmonary arteries from
cholesterol-fed rabbits, methacholine produced an
enhanced relaxation response (Fig 3
; maximal relaxation,
44±4%)
compared with that in normal rabbits. An additional experiment examined
the effect of the specific NO synthase inhibitor LNA on
methacholine-induced contractions in
cholesterol-fed and normal NZW rabbit pulmonary
arteries. In normal NZW rabbits, pretreatment with LNA had no effect on
the vascular contractions observed with methacholine (Fig 4A
).
LNA pretreatment enhanced methacholine-induced
contractions in cholesterol-fed rabbits (Fig 4B
). The
maximal contractile response to methacholine in the presence of LNA was
106±10% compared with 77±9% in the absence of LNA.
Interestingly,
pretreatment of pulmonary arteries with
L-arginine for 45 minutes before LNA and methacholine
administration did not block the enhanced response observed in the
presence of LNA alone (Fig 4B
).
|
|
NO release was compared in vessels obtained from
cholesterol-fed and normal NZW rabbits and stimulated
with methacholine (10-5 mol/L).
Cholesterol feeding had no effect on the production
of total nitrite (NO2- plus
NO3-) in pulmonary arteries
compared with rabbits fed the standard rabbit chow (63.2±14.9 versus
60.5±20.4 nmol/mg). To further characterize NO synthase activity, we
assayed protein extracts from cholesterol-fed and
normal rabbit pulmonary arteries for the conversion of
[3H]arginine to [3H]citrulline.
Measurement
of NO synthase activity again indicated that the activity in
pulmonary artery homogenates from
cholesterol-fed and normal NZW rabbits did not differ
(Table 2
). The specificity for NO synthase activity was
verified by the addition of the NO synthase inhibitor LNA
to the protein extracts. Removal of calcium from the reaction buffer
blocked NO synthase activity in both normal and
cholesterol-fed rabbits.
|
A final experiment examined the role of
endothelium-derived hyperpolarizing factor in the
decreased contractions observed in cholesterol-fed
rabbits. Pretreatment with the calcium-dependent potassium channel
blocker charybdotoxin produced a slight increase in
methacholine-induced contractions in
cholesterol-fed rabbits only at the highest
concentration of methacholine (Fig 5
). Charybdotoxin had no
effect on contractile responses in normal rabbits (data not shown).
|
| Discussion |
|---|
|
|
|---|
The contractile response to methacholine in
cholesterol-fed rabbits also depended on an intact
endothelium. It is conceivable that the decreased
response to methacholine was due to a decreased production of
TXA2 by the cholesterol-fed rabbit
pulmonary arteries. Production of
TXB2, the stable metabolite of
TXA2, did not differ in segments of
pulmonary arteries obtained from
cholesterol-fed and normal rabbits, either in the basal
state or when the vessels were stimulated with methacholine. Because
the endothelium is the source of the vasodilator
prostaglandin PGI2, it was also possible
that methacholine caused a greater release of PGI2 in the
cholesterol-fed rabbits and that this vasodilator
prostanoid contributed to the depressed contractile response. However,
6-keto-PGF1
production did not
differ in vessels from the two groups of rabbits.
Another possible explanation for the observed reduced contractile responses could be an alteration in the vascular smooth muscle TXA2 receptor or postreceptor events in cholesterol-fed rabbits. Evidence exists that other receptors are altered by atherosclerosis.30 Studies have also shown that the vascular TXA2 receptor appears to be regulated by various experimental conditions.31 32 33 For example, administration of dexamethasone to rabbits causes a decrease in TXA2 receptor density in aortic membranes.32 Dexamethasone-treated rabbit aortas also exhibit decreased contractions to the TXA2 mimetic U46619. We have also shown that a subgroup of normal NZW rabbits lack the TXA2 vascular receptor and fail to contract to methacholine, arachidonic acid, or U46619.33 In the present study, although methacholine-induced contractions were less in cholesterol-fed rabbit pulmonary arteries, contractions to arachidonic acid and U46619 were unaltered. Thus, it seems unlikely that a decrease in vascular TXA2 receptors or postreceptor events explains the depressed contractile response to methacholine.
An alternative explanation for the decreased contractions to methacholine was suggested by the enhanced relaxations to methacholine in cholesterol-fed rabbit pulmonary arteries compared with arteries of normal rabbits. Methacholine releases the vasodilator NO34 and the vasoconstrictor endothelium-derived contracting factor or TXA2.19 In pulmonary arteries, the effect of methacholine in precontracted vessels is a small relaxation at low concentrations and vasoconstriction at higher concentrations. If precontracted pulmonary arteries from normal NZW rabbits were pretreated with a specific TXA2 receptor antagonist, the major response to the administration of methacholine was relaxation.33 These results indicate that NO-induced relaxation is unmasked by blockade of the vasoconstrictor TXA2. In the present study, it is possible that the pulmonary arteries from cholesterol-fed rabbits have greater relaxations to methacholine compared with those from normal rabbits because cholesterol-fed rabbit pulmonary arteries have an increased production of NO. As support for this hypothesis, the NO synthase inhibitor LNA enhanced the contractions in cholesterol-fed pulmonary arteries but had no effect on normal pulmonary arteries. A recent report by Verbeuren and coworkers35 showed a similar effect in aortas of atherosclerotic rabbits. In their study, rabbits were fed an elevated cholesterol diet for 30 weeks compared with our study, in which the rabbits received the diet for only 2 weeks. In both studies, the rabbits developed hypercholesterolemia; however, the rabbits from the study by Verbeuren et al developed atherosclerotic lesions. They also found that the NO synthase inhibitor enhanced basal tone and norepinephrine-induced contractions. No effect of the inhibitor was observed in age-matched control rabbit aortas.
It should be noted that other studies have reported that hypercholesterolemia and atherosclerosis impair endothelium-dependent relaxations.5 6 7 8 In vessels from cholesterol-fed rabbits, NO synthesis was not impaired.36 Instead, the decreased relaxation response was due to an increased inactivation of NO by superoxide radicals formed in the intima of atherosclerotic arteries.37 The present study also indicates that NO production was not altered in hypercholesterolemia. First, the production of nitrite/nitrate did not differ between cholesterol-fed and normal rabbits. Second, NO synthase activity was not different in cholesterol-fed pulmonary artery homogenates. The inability of L-arginine to reverse the effect of LNA on the enhancement of methacholine-induced contractions was unexpected. This result suggests that the effect of LNA in isolated blood vessels is unrelated to its effect to inhibit NO synthase.
Recent evidence in hypercholesterolemic rabbit carotid arteries showed that relaxations to acetylcholine are mediated by an endothelium-derived hyperpolarizing factor38 that appears to be distinct from NO. Although the identity of this factor is presently unknown, it is proposed that it opens potassium channels on vascular smooth muscle cells, causing hyperpolarization and relaxation. In the study by Najibi and coworkers,38 relaxations to acetylcholine were not impaired in carotid arteries from cholesterol-fed rabbits compared with those from normal rabbits. The calcium-dependent potassium channel blocker charybdotoxin reduced acetylcholine-induced relaxations in carotid arteries obtained from cholesterol-fed rabbits but had no effect on relaxations in normal rabbit carotid arteries. The authors concluded that although the relaxations in the cholesterol-fed and normal rabbit carotid arteries were similar, the response was mediated by different mechanisms. Our study investigated the role of endothelium-derived hyperpolarizing factor in the altered vascular responses to methacholine in cholesterol-fed rabbit pulmonary arteries. We found that charybdotoxin increased contractions in cholesterol-fed rabbit pulmonary arteries only at the highest concentration of methacholine. Although further characterization studies are necessary, our initial results do not indicate that endothelium-derived hyperpolarizing factor mediates the altered contractile responses in hypercholesterolemic blood vessels.
A limited number of studies have investigated vascular responses in pulmonary arteries from cholesterol-fed animals. The reason for this lack of studies is unclear because it is known that human pulmonary hypertension is often associated with pulmonary artery atherosclerotic lesions.23 24 25 However, Ibengwe and Suzuki39 did investigate pulmonary artery responses in rabbits fed a 1% cholesterol diet for 12 weeks. The authors reported enhanced contractions to KCl and decreased contractions to norepinephrine. Pulmonary arteries from the cholesterol-fed rabbits also had diminished relaxations to acetylcholine. Although these studies did not evaluate pathological changes in the pulmonary arteries, Zhu et al40 showed that rabbits fed a 0.3% cholesterol diet for 10 weeks had increased pulmonary artery lesions as assessed by Sudan IV staining. Therefore, despite limited studies in rabbit pulmonary artery, there is evidence that these vessels develop atherosclerotic lesions and have altered vascular responses. In all cases, however, rabbits were fed the cholesterol diet for a period long enough to produce atherosclerotic lesions. In contrast, our study investigated the early changes that occur in blood vessels with hypercholesterolemia before the development of the atherosclerotic lesion.
In conclusion, the present study demonstrates that hypercholesterolemia decreases pulmonary artery vascular contractions and increases relaxations to methacholine. This effect is not mediated by a decreased production of the endothelium-dependent constrictor TXA2 or by an increased production of the endothelium-derived relaxing factor NO. Our results also indicate that in hypercholesterolemic vessels, activation of potassium channels by endothelium-derived hyperpolarizing factor does not modulate vascular tone. It is well recognized that in humans the pulmonary circulation is not the primary vascular bed that develops atherosclerosis.41 However, it is also known that pulmonary arteries do become atherosclerotic even though the manifestation of the disease is less severe than what is observed in the coronary arteries.23 42 Interestingly, in pulmonary hypertension, either primary or secondary forms, atherosclerosis is much more pronounced and plaque formation is observed in both large- and small-diameter vessels.24 Therefore, this study gives important new information regarding the vascular changes that occur in pulmonary vessels during the development of atherosclerosis. Although the mechanism mediating the altered vascular responses is still unknown, the results from this study clearly indicate that the regulation of vascular tone is different in normal and hypercholesterolemic vessels.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Inkeles S, Eisenberg D. Hyperlipidemia and coronary atherosclerosis: a review. Medicine (Baltimore). 1981;60:110-123. [Medline] [Order article via Infotrieve]
3. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500. [Medline] [Order article via Infotrieve]
4. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018. [Abstract]
5.
Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE,
Coene M, Herman AG. Effect of
hypercholesterolemia on vascular reactivity in
the rabbit, I: endothelium-dependent and
endothelium-independent contractions and
relaxations in isolated arteries of control and
hypercholesterolemic rabbits.
Circ Res. 1986;58:552-564.
6.
Galle J, Busse R, Bassenge E.
Hypercholesterolemia and
atherosclerosis change vascular reactivity in rabbits
by different mechanisms. Arterioscler
Thromb. 1991;11:1712-1718.
7. Harrison DG, Freiman PC, Armstrong ML, Marcus ML, Heistad DD. Alterations of vascular reactivity in atherosclerosis. Circ Res. 1987;61(suppl II):II-74-II-80.
8.
Jayakody L, Senaratine M, Thomson A, Kappagoda
T. Endothelium-dependent relaxation in
experimental atherosclerosis in the rabbit.
Circ Res. 1987;60:251-264.
9. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JR. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69-102. [Medline] [Order article via Infotrieve]
10. Dembinska-Kiec A, Gryglewski T, Zmuda A, Gryglewski RJ. The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits. Prostaglandins. 1977;14:1025-1034. [Medline] [Order article via Infotrieve]
11. Gryglewski RJ, Dembinska-Kiec A, Zmuda A, Gryglewski J. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis. 1978;31:385-394. [Medline] [Order article via Infotrieve]
12.
Pfister SL, Falck JR, Campbell WB. Enhanced
synthesis of epoxyeicosatrienoic acids by
cholesterol-fed rabbit aorta. Am J
Physiol. 1991;261:H843-H852.
13. Pritchard KA Jr, Wong PY-K, Stemerman MB. Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products. Am J Pathol. 1990;136:1383-1391. [Abstract]
14. Fitzpatrick FA, Murphy RC. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of `epoxygenase'-derived eicosanoids. Pharmacol Rev. 1988;40:229-241. [Medline] [Order article via Infotrieve]
15. Rosolowsky M, Falck JR, Campbell WB. Synthesis and biological activity of epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Adv Prostaglandin Thromboxane Leukot Res. 1990;21:213-216.
16.
Rosolowsky M, Campbell WB. Role of
PGI2 and epoxyeicosatrienoic acids in relaxation of bovine
coronary arteries to arachidonic acid.
Am J Physiol. 1993;264:H327-H335.
17. Yanagisawa M, Masaki T. Endothelin, a novel endothelium-derived peptide. Biochem Pharmacol. 1989;38:1877-1883. [Medline] [Order article via Infotrieve]
18.
Alteire RJ, Kiritsy-Roy JA, Catravas JD.
Acetylcholine-induced contractions in isolated rabbit
pulmonary arteries: role of thromboxane
A2. J Pharmacol Exp Ther. 1986;236:535-541.
19.
Buzzard CJ, Pfister SL, Campbell WB.
Endothelium dependent contractions in rabbit
pulmonary artery are mediated by thromboxane
A2. Circ Res. 1993;72:1023-1034.
20. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Potentiation of vasoconstrictor responses to serotonin in the limb of atherosclerotic monkeys. J Hypertens. 1986;4(suppl 1):S17-S21.
21. Bloom D, McCalden TA, Rosendorff C. The effects of hypercholesterolaemic plasma on vascular sensitivity to noradrenaline. Br J Pharmacol. 1975;54:421-427. [Medline] [Order article via Infotrieve]
22.
Yokoyama M, Henry PD. Sensitization of isolated
canine coronary arteries to calcium ions after exposure to
cholesterol. Circ Res. 1975;45:479-486.
23.
Brenner O. Pathology of the vessels of the
pulmonary circulation. Arch Intern Med. 1935;56:211-221.
24. Heath D, Wood EH, DuShane JW, Edwards JE. The relation of age and blood pressure to atheroma in the pulmonary arteries and thoracic aorta in congenital heart disease. Lab Invest. 1960;9:259-265. [Medline] [Order article via Infotrieve]
25. Sevitt S, Walton KW. Atherosclerotic lesions from the reduction of pulmonary emboli. Atherosclerosis. 1986;59:173-185. [Medline] [Order article via Infotrieve]
26. Campbell WB, Ojeda SR. Measurement of prostaglandin by radioimmunoassay. Methods Enzymol. 1987;141:323-341. [Medline] [Order article via Infotrieve]
27. Hevel JM, Marletta MA. Nitric oxide synthase assays. Methods Enzymol. 1994;233:250-258. [Medline] [Order article via Infotrieve]
28. Pratt PF, Nithipatikom K, Campbell WB. Simultaneous determination of nitrate and nitrite in biological samples by multichannel flow injection analysis. Anal Biochem. 1995;231:383-386. [Medline] [Order article via Infotrieve]
29. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138. [Medline] [Order article via Infotrieve]
30. Tsutsumi S, Tsuji K, Ogawa K, Ito T, Satake T. Effect of dietary salt and cholesterol loading on vascular adrenergic receptors. Blood Vessels. 1988;25:209-216. [Medline] [Order article via Infotrieve]
31.
Masuda A, Mathur R, Halushka PV. Testosterone
increases thromboxane A2 receptors in cultured
rat aortic smooth muscle cells. Circ Res. 1991;69:638-643.
32.
Sessa WC, Halushka PV, Okwu A, Nasjletti A.
Characterization of the vascular thromboxane
A2/prostaglandin
endoperoxide receptor in rabbit aorta.
Circ Res. 1990;67:1562-1569.
33.
Buzzard CJ, Pfister SL, Halushka PV, Campbell
WB. Decrease in vascular TxA2 receptors in a
subgroup of rabbits unresponsive to a TxA2 mimetic. Am J
Physiol. 1994;266:H2320-H2326.
34. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vivo and in vitro. Br J Pharmacol. 1990;101:746-752.[Medline] [Order article via Infotrieve]
35. Verbeuren TJ, Bonhomme E, Laubie M, Simonet S. Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiol Pharmacol. 1993;21:841-845. [Medline] [Order article via Infotrieve]
36. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2116.
37.
Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad
DD, Harrison DG. Chronic treatment with
polyethylene-glycolated superoxide dismutase partially restores
endothelium-dependent vascular relaxations in
cholesterol-fed rabbits. Circ
Res. 1991;69:1293-1300.
38.
Najibi S, Cowan CL, Palacino JJ, Cohen RA.
Enhanced role of potassium channels in relaxations to acetylcholine in
hypercholesterolemic rabbit carotid artery.
Am J Physiol. 1994;266:H2061-H2067.
39. Ibengwe JK, Suzuki H. Changes in mechanical responses of vascular smooth muscles to acetylcholine, noradrenaline and high-potassium solution in hypercholesterolemic rabbits. Br J Pharmacol. 1986;87:395-402. [Medline] [Order article via Infotrieve]
40. Zhu B, Smith DL, Sievers RE, Isenberg WM, Parmley WW. Inhibition of atherosclerosis by fish oil in cholesterol-fed rabbits. J Am Coll Cardiol. 1988;12:1073-1078. [Abstract]
41. Woolf, N. Hemodynamic factors and plaque formation. In: Woolf N, ed. Pathology of Atherosclerosis. London, UK: Butterworth Scientific; 1982:189-193.
42. Glagov S, Ozoa AK. Significance of the relatively low incidence of atherosclerosis in the pulmonary, renal and mesenteric arteries. Ann N Y Acad Sci. 1968;149:940-955.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
X. Tang, N. Aggarwal, B. B. Holmes, H. Kuhn, and W. B. Campbell Age-related decrease in 15-lipoxygenase contributes to reduced vasorelaxation in rabbit aorta Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H679 - H687. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tang, B. B. Holmes, K. Nithipatikom, C. J. Hillard, H. Kuhn, and W. B. Campbell Reticulocyte 15-Lipoxygenase-I Is Important in Acetylcholine-Induced Endothelium-Dependent Vasorelaxation in Rabbit Aorta Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 78 - 84. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |